Hepatocellular carcinoma (HCC) is a leading cause of cancerrelated death worldwide, and
is increasing in incidence in Australia.• For most people with cirrhosis and chronic hepatitis …

Purpose Hepatocellular carcinoma (HCC) is most often a sequela of chronic liver disease or
chronic hepatitis B infection. Among high-risk patients, surveillance for HCC every 6 months …

Background Aboriginal and Torres Strait Islander Australians living with chronic hepatitis B
virus (HBV) infection have a significant burden of hepatocellular carcinoma (HCC). The …

Background and objectives In Australia, mortality rates for hepatocellular carcinoma (HCC)
are rising. Targeted surveillance is recommended to increase early diagnosis. The aim of …

Aims: Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer.
While patients who are known to be at high risk for HCC should be under surveillance, only …

Introduction Aboriginal and Torres Strait Islander Australians living in remote locations suffer
disproportionately from chronic hepatitis B (CHB). Defining the temporospatial epidemiology …

BACKGROUND While clinical guidelines recommend hepatocellular carcinoma (HCC)
surveillance for at-risk individuals, reported surveillance rates in the United States and …

African-Australians have a high prevalence of chronic hepatitis B (CHB) and an increased
risk of liver cancer (hepatocellular carcinoma, HCC) at a younger age than other affected …

Introduction: Liver cancer is the only cancer in Australia for which mortality rates have
consistently risen, despite tests to identify high-risk individuals. Hepatocellular carcinoma …

Background General practice plays a critical role in the prevention, diagnosis, management,
and survivorship care of patients with cancer. Mapping research outputs over time provides …